Efficacy and safety of olodaterol once daily delivered via Respimat(®) in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

BACKGROUND: Olodaterol is a long-acting β(2)-agonist with a 24-hour bronchodilator profile. Two replicate, randomized, double-blind, placebo-controlled, parallel-group, Phase III trials were performed as part of a comprehensive clinical program to investigate the long-term safety and efficacy of olo...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Ferguson, Gary T, Feldman, Gregory J, Hofbauer, Peter, Hamilton, Alan, Allen, Lisa, Korducki, Lawrence, Sachs, Paul
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2014
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4064950/
https://ncbi.nlm.nih.gov/pubmed/24966672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S61717
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍